Status:
UNKNOWN
The Role of Acupuncture-induced Exosome in Treating Post-stroke Dementia
Lead Sponsor:
China Medical University Hospital
Conditions:
Exosome
Post-stroke Dementia
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
Stroke is the main cause of disability and the second main cause of dementia. Approximately 21.5% of patients develop dementia within 4 years after stroke. The main clinical manifestation of dementia ...
Eligibility Criteria
Inclusion
- History of stroke.
- MMSE score between 16 and 26.
Exclusion
- Those with serious diseases, such as heart failure, chronic failure or cancer patients, etc.
- Intolerance to acupuncture treatment.
- Allergy to acupuncture needles.
- Refusal to sign the informed consent form.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05326724
Start Date
August 1 2022
End Date
July 31 2025
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, North District, Taiwan, 40447